Top cancer drugs based on revenue worldwide 2017

The data shows the top ten oncology products worldwide in 2017, ranked by revenue. The second product on this list wis Rituxan, a cancer drug from Swiss-based company Roche. Rituxan is used for the treatment for common forms of blood cancer, including non-Hodgkin's lymphoma (NHL), follicular lymphoma and chronic lymphocytic leukaemia (CLL), but it can also be used to treat rheumatoid arthritis and certain types of vasculitis.